Dual agonists extend this by adding GIP receptor activity alongside GLP-1 receptor activity
Pataer A, Hu W, Lu X, Chada S, Roth, J, Hunt K, Swisher S
Payers should also consider the range of coverage expansion options available that best optimize the cost to plan sponsors while providing members access to these revolutionary GLP-1 drugs
How it works mechanism of action Retatrutide is the only triple agonist GLP-1 + GIP + glucagon
GLP-1 Offerings and Weight Loss Services GobyMeds offers both compounded and brand-name GLP-1 options: Compounded Medications (primary offering): Compounded Semaglutide (injectable) the active ingredient in Ozempic and Wegovy
UnitedHealthcare approval varies by specific plan and medical documentation quality